NCT01972932View on ClinicalTrials.gov

Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea

PHASE4TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

August 31, 2017

Conditions
Clostridium Difficile InfectionAntibiotic Associated Diarrhea
Interventions
DIETARY_SUPPLEMENT

Bio K+® 2 capsules orally (or via nasogastric tube)

Bio-K+® 2 capsules orally (or via nasogastric tube) once per day starting at randomization until five days after the discontinuation of the antibiotic.

DIETARY_SUPPLEMENT

Placebo

Placebo Comparator: 2 capsules orally (or via nasogastric tube) once per day starting randomization until five days after the discontinuation of the antibiotic.

Trial Locations (1)

Unknown

Centre Hospitalier de l'Université de Montréal, Montreal

Sponsors
All Listed Sponsors
collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

lead

Bio-K Plus International Inc.

INDUSTRY

NCT01972932 - Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea | Biotech Hunter | Biotech Hunter